181 related articles for article (PubMed ID: 12657933)
61. Anaplastic large cell lymphoma in leukemic phase: extraordinarily high white blood cell count.
Nguyen JT; Condron MR; Nguyen ND; De J; Medeiros LJ; Padula A
Pathol Int; 2009 May; 59(5):345-53. PubMed ID: 19432678
[TBL] [Abstract][Full Text] [Related]
62. Clinical presentation of anaplastic large-cell lymphoma in the central nervous system.
Nomura M; Narita Y; Miyakita Y; Ohno M; Fukushima S; Maruyama T; Muragaki Y; Shibui S
Mol Clin Oncol; 2013 Jul; 1(4):655-660. PubMed ID: 24649224
[TBL] [Abstract][Full Text] [Related]
63. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.
Xing X; Feldman AL
Adv Anat Pathol; 2015 Jan; 22(1):29-49. PubMed ID: 25461779
[TBL] [Abstract][Full Text] [Related]
64. Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management.
Shustov A; Soma L
Cancer Treat Res; 2019; 176():127-144. PubMed ID: 30596216
[TBL] [Abstract][Full Text] [Related]
65. Primary leptomeningeal ALK+ lymphoma in a 13-year-old child.
Merlin E; Chabrier S; Verkarre V; Cramer E; Delabesse E; Stéphan JL
J Pediatr Hematol Oncol; 2008 Dec; 30(12):963-7. PubMed ID: 19131793
[TBL] [Abstract][Full Text] [Related]
66. Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma.
Foyil KV; Bartlett NL
Cancer J; 2012; 18(5):450-6. PubMed ID: 23006951
[TBL] [Abstract][Full Text] [Related]
67. ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Meijer CJ
J Pathol; 2003 May; 200(1):4-15. PubMed ID: 12692835
[TBL] [Abstract][Full Text] [Related]
68. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
Pittaluga S; Wlodarska I; Pulford K; Campo E; Morris SW; Van den Berghe H; De Wolf-Peeters C
Am J Pathol; 1997 Aug; 151(2):343-51. PubMed ID: 9250148
[TBL] [Abstract][Full Text] [Related]
69. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
[TBL] [Abstract][Full Text] [Related]
70. Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma.
Khoury JD; Medeiros LJ; Rassidakis GZ; Yared MA; Tsioli P; Leventaki V; Schmitt-Graeff A; Herling M; Amin HM; Lai R
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3692-9. PubMed ID: 14506160
[TBL] [Abstract][Full Text] [Related]
71. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
Colleoni GW; Bridge JA; Garicochea B; Liu J; Filippa DA; Ladanyi M
Am J Pathol; 2000 Mar; 156(3):781-9. PubMed ID: 10702393
[TBL] [Abstract][Full Text] [Related]
72. Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma.
Kutok JL; Aster JC
J Clin Oncol; 2002 Sep; 20(17):3691-702. PubMed ID: 12202671
[TBL] [Abstract][Full Text] [Related]
73. Correlation of seven biological factors (Hsp90a, p53, MDM2, Bcl-2, Bax, Cytochrome C, and Cleaved caspase3) with clinical outcomes of ALK+ anaplastic large-cell lymphoma.
Li HL; Huang XP; Zhou XH; Ji TH; Wu ZQ; Wang ZQ; Jiang HY; Liu FR; Zhao T
Biomed Environ Sci; 2011 Dec; 24(6):630-41. PubMed ID: 22365399
[TBL] [Abstract][Full Text] [Related]
74. Small Cell Variant of Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma of the Dura Mimicking Tentorial Meningioma.
Hirano Y; Miyawaki S; Satou M; Taoka K; Toyama K; Ikemura M; Tanaka R; Takayanagi S; Tanaka S; Nakatomi H; Kurokawa M; Saito N
World Neurosurg; 2020 Jun; 138():169-173. PubMed ID: 32151774
[TBL] [Abstract][Full Text] [Related]
75. Characteristics And Outcomes Of Anaplastic Large Cell Lymphoma Patients-A Single Centre Experience.
Athar S; Siddiqui N; Hameed A
J Ayub Med Coll Abbottabad; 2017; 29(1):37-41. PubMed ID: 28712170
[TBL] [Abstract][Full Text] [Related]
76. Anaplastic large cell lymphomas presented as bone lesions: a clinicopathologic study of six cases and review of the literature.
Nagasaka T; Nakamura S; Medeiros LJ; Juco J; Lai R
Mod Pathol; 2000 Oct; 13(10):1143-9. PubMed ID: 11048810
[TBL] [Abstract][Full Text] [Related]
77. Case report: A unique pediatric case of a primary CD8 expressing ALK-1 positive anaplastic large cell lymphoma of skeletal muscle.
Gaiser T; Geissinger E; Schattenberg T; Scharf HP; Dürken M; Dinter D; Rosenwald A; Marx A
Diagn Pathol; 2012 Apr; 7():38. PubMed ID: 22497840
[TBL] [Abstract][Full Text] [Related]
78. Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8(+) T cell responses in children with NPM-ALK(+) anaplastic large cell lymphoma.
K Singh V; Werner S; Hackstein H; Lennerz V; Reiter A; Wölfel T; Damm-Welk C; Woessmann W
Clin Exp Immunol; 2016 Oct; 186(1):96-105. PubMed ID: 27414060
[TBL] [Abstract][Full Text] [Related]
79. Primary central nervous system ALK-negative anaplastic large cell lymphoma: a case report and literature review.
Yuan C; Duan H; Wang Y; Zhang J; Ou J; Wang W; Zhang M
Ann Palliat Med; 2022 Apr; 11(4):1554-1560. PubMed ID: 34263607
[TBL] [Abstract][Full Text] [Related]
80. Dural-Based Primary Central Nervous System Lymphoma with Bone Invasion.
Lee SW; Jung TY; Baek HJ; Kim SK; Lee KH
World Neurosurg; 2020 Jul; 139():415-418. PubMed ID: 32360734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]